Teladoc Health (TDOC) Projected to Post Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is projected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Teladoc Health Trading Down 8.5 %

Shares of NYSE TDOC opened at $13.12 on Wednesday. The business has a 50 day simple moving average of $10.41 and a 200 day simple moving average of $9.35. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $20.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.95% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

TDOC has been the subject of several recent research reports. Royal Bank of Canada boosted their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. TD Cowen decreased their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. The Goldman Sachs Group upped their target price on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $12.18.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.